Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Central Nervous System Disorders Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Depression Drugs, Multiple Sclerosis Drugs, Schizophrenia Drugs, Bipolar Disorder Therapeutics, Epilepsy Drugs, Others), By Drug Class (Analgesics, Antidepressant, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Central Nervous System Disorders Therapeutics market size is poised to register 6.94% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Neurology Clinical Trials Market Size, Trends, Analysis, and Outlook By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), by Region, Country, Segment, and Companies, 2024-2030
... Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Neurology Clinical Trials market size is poised to register 5.35% growth from 2024 to 2030, ... Read More
-
Continence Care Market Size, Trends, Analysis, and Outlook By Product (Urinary Catheters, Catheter Maintenance/Care, Urinary Bags), By Application (Diabetes, Strokes, BPH, Alzheimer, Cerebral Palsy, Parkinson, Prostate cancer, Spinal Cord Injury, Bladder Cancer, Multiple sclerosis, Spina Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), by Region, Country, Segment, and Companies, 2024-2030
... Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Continence Care market size is poised to register 5.61% growth ... Read More
-
Medical Marijuana Market Size, Trends, Analysis, and Outlook By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Medical Marijuana market size is poised to register 21.66% growth from 2024 to 2030, presenting significant growth ... Read More
-
Deep Brain Stimulation in Parkinson's Disease Market Size, Trends, Analysis, and Outlook By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers), by Region, Country, Segment, and Companies, 2024-2030
... The global Deep Brain Stimulation in Parkinson's Disease market size is poised to register 10.92% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Neurorehabilitation Devices Market Size, Trends, Analysis, and Outlook By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others), By Therapy Area (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Neurorehabilitation Devices market size is poised to register 12.13% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurorehabilitation Devices ... Read More
-
Brain Implants Market Size, Trends, Analysis, and Outlook By Product (Deep Brain Stimulator, Spinal Cord Stimulator, Vagus Nerve Stimulator), By Application (Chronic pain, Epilepsy, Parkinson's, Depression, Essential Tremor, Alzheimer's), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Brain Implants market size is poised to register 10.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Brain Implants ... Read More
-
Optogenetics Actuators and Sensors Market Size, Trends, Analysis, and Outlook By Product (Actuators, Sensors), By Disease Type, Retinal Disorders, Parkinson’s Disease, Anxiety & Depression, Autism, Schizophrenia, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Optogenetics Actuators and Sensors market size is poised to register 2.74% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Optogenetics Actuators ... Read More
-
Brain Monitoring Device Market Size, Trends, Analysis, and Outlook By Type (Magnetic Resonance Imaging (MRI) Scanners, Computerized Tomography (CT) Scanners, Electroencephalograph (EEG) Devices, Positron Emission Tomography (PET) Scanners, Sleep Monitoring Devices, Cerebral Oximeters, Electromyography (EMG) Devices, Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Wet Electrodes, Dry Electrodes, Needle Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure (Devices for Invasive Procedures, Devices for Non-invasive Procedures), By Modality (Fixed, Portable, Wearable), By Medical Condition (Traumatic Brain Injury (TBI), Stroke, Dementia, Headache Disorders, Sleep Disorders, Parkinson’s Disease, Epilepsy, Huntington's Disease, Other Medical Conditions), By End-User (Hospitals, Neurology Centers, Ambulatory Surgery Centers (ASCs) & Cli
... Devices, Intracranial Pressure (ICP) Monitors, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices), By Accessories (Electrodes, Wet Electrodes, Dry Electrodes, Needle Electrodes, Sensors, Pastes & Gels, Caps, Cables, Batteries, Others), By Usability (Disposable, Reusable), By Procedure ... Read More
-
Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030
... diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Neurological Biomarkers market size is poised to register 14.63% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Drug Delivery Across Blood-Brain Barrier Market Size, Trends, Analysis, and Outlook By Drug Delivery Technology (Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion, Others), By Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030
... Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Drug Delivery Across Blood-Brain Barrier market size is poised to register 19.61% growth from 2024 to 2030, ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Immunoassay for Neurological Biomarkers market size is poised to register 17.33% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Drugs for Parkinson's Diseases
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Drugs for Alzheimer's and Parkinson's Diseases
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Parkinson's Disease Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Disorders
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Parkinson's Disease Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Anti-Parkinson's Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Parkinson's Disease Deep Brain Stimulation Devices
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Parkinson's Disease Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Neurological Biomarkers for Alzheimers and Parkinsons Diseases
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Deep Brain Stimulation Devices for Parkinson's Diseases
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
Deep Brain Stimulation Market Report by Stimulation Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Application (Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2024-2032
... Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2024-2032 The global deep brain stimulation market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group ... Read More
-
Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Parkinson's Disease Treatments is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
Research Assistance
